Trophoblastic gestational neoplasia in the Center Hospital Pereira Rossell between 2019 and 2023:
a series of cases
Abstract
Introduction: Gestational trophoblastic neoplasia (GTN) refers to malignant tumors originating from the hyperproliferation of placental tissue following abnormal fertilization. Although it occurs infrequently in daily practice, it has a significant impact on patients’ reproductive prognosis. The objective of this study is to describe the cases of GTN occurring at the center Hospital Pereira Rossell, the diagnosis and treatment of this pathology and compare them with established international guidelines standards.
Methodology: An observational, descriptive, cross-sectional case series study was conducted between the years 2019 and 2023 at said center.
Discussion: Seven cases of GTN were found; five were invasive molar pregnancy and two were choriocarcinoma. The majority were staged as FIGO stage III (71.4%) and mostly had a low-risk prognostic score (57.1%). Treatment was administered according to international guidelines in all the GTN cases.
Conclusions: In six of the seven cases, a diagnostic and therapeutic approach consistent with international recommendations was followed, allowing for appropriate treatment and follow-up. Patients who adhered well to treatment showed a favorable outcome, with a generally positive prognosis, even in higher-risk cases.
Downloads
References
Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, et al. Gestational Trophoblastic Neoplasia, version 2.2019, NCCN clinical practice Guidelines in oncology. J Natl Compr Canc Netw (Internet).
;17(11):1374–91. Disponible en: https://jnccn.org/configurable/content/journals$002fjnccn$002f17$002f11$002farticle-p1374.
Coronado PJ, Marquina G, Diestro M. Enfermedad trofoblástica gestacional (Internet). Prog Obstet Ginecol. 2020;63(3):165-184. Disponible en: https://sego.es/documentos/progresos/v63-2020/n3/05-GAP-enfermedad
trofoblastica-gestacional.pdf
Sumba A, Godoy M, Silvera J, Alonso I. Enfermedad trofoblástica gestacional: Revisión diagnóstica y terapéutica. Revista De Oncología Médica. 2019;11(1):45–53. ISSN: 1688-6623. Disponible en: https://www.comisioncancer.org.uy/Ocultas/Revista-de-Oncologia-Medica-uc240
Benedet JL (ed). FIGO Committee on Gynecologic Oncology. Staging classifications and clinical practice guidelines of gynecologic cancers. 3d. FIGO Committee on Gynecologic Oncology; 2003.
Universidad de la República. Facultad de Medicina. Cátedra de Oncología Clínica. Pautas de oncología médica para el diagnóstico, tratamiento sistémico y seguimiento. Montevideo: FMED, 2023. Pág. 354-351.
Hospital Clinic. Hospital Sant Joan de Déu, Universidad de Barcelona. Protocolo Manejo de la Mola Hidatiforme. Barcelona, España: Universidad de Barcelona; 2019. www.medicinafetalbarcelona.org.
Espinoza Artavia A, Fernández Vaglio R, Solar del Valle T. Actualización en patología trofoblástica gestacional: mola hidatiforme y neoplasias. Rev. méd. sinerg. (Internet). 2019;4(5):44-59. (citado 24 de abril de 2024). Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/193
Banerjee D, Barsode SD, Basu P. Management of gestational trophoblastic diseases-an update. Rev Recent Clin Trials. 2015;10(4):255-62.
Lawrie TA1, Alazzam M, Tidy J, Hancock BW, Osborne R. First-line chemotherapy in low-risk gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2016;(6):CD007102. doi: 10.1002/14651858.CD007102.
pub4.
Consejo editorial del PDQ sobre el tratamiento para adultos. Tratamiento de la enfermedad trofoblástica gestacional: versión para profesionales de salud 2022. En: PDQ Cancer Information Summaries (Internet). Bethesda (MD): Instituto Nacional del Cáncer (EE. UU.); 2002. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK65977.
Lurain JR. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol (Internet). 2011;204(1):11–8. Disponible en: http://dx.doi.org/10.1016/j.ajog.2010.06.072
Bianconi M, Bayo J, Costa J, Vico C, Goldsman M. Consenso FASGO “enfermedad trofoblastica gestacional”. FASGO; 2015. Disponible en: https://www.fasgo.org.ar/archivos/consensos/CONSENSO_FASGO_ETG.pdf
Mendes da Silva AL, do Nascimento Monteiro K, Yazaki Sun S, Urban Borbely A. Gestational trophoblastic neoplasia: Novelties and challenges. Sience Direct; 2021. Vol. 116. Pág. 38-42. https://doi.org/10.1016/j.placenta.2021.02.013
Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ (Internet). 2020;371:m4087. Disponible en: http://dx.doi.org/10.1136/bmj.m4087
Copyright (c) 2026 María Eugenia Fernández Vaz, Florencia Fregni Zúñiga, María Fernanda Moll Paradela, Josefina Tarigo
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain their copyright and assign to the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons Attribution 4.0 International License. that allows sharing the work as long as the initial publication in this magazine is indicated.
